M.D. Arie Belldegrun - Director at Allogene Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
ALLO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by M.D. Arie Belldegrun since 18 Feb 2025

Holdings reported by M.D. Arie Belldegrun for Allogene Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,236,816 $3,064,437 $1.37 02 Feb 2026 Direct
Common Stock 539,867 $739,617 $1.37 02 Feb 2026 Indirect
Stock Option (Right to buy) 929,913 02 Feb 2026 Direct Common Stock
Restricted Stock Unit 263,033 02 Feb 2026 Direct Common Stock

Transactions reported by M.D. Arie Belldegrun for Allogene Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.